Choroba zastawki aorty
Rokowania, prognozy i postęp choroby

Choroba zastawki aorty, zwłaszcza stenoza aortalna, jest związana z wysokim ryzykiem śmiertelności, szczególnie po wystąpieniu objawów takich jak duszność czy ból w klatce piersiowej, gdzie średnia przeżywalność bez leczenia wynosi 1-2 lata. Stopień zwężenia zastawki aorty istotnie wpływa na rokowanie, z umiarkowanym zwężeniem zwiększającym ryzyko o współczynnik 1,57 (95% CI: 1,38-1,52; P <0,001), a ciężkim zwężeniem ponad dwukrotnie (współczynnik ryzyka 2,50; 95% CI: 2,32-2,70; P <0,001). Kluczowymi predyktorami złego rokowania są mniejsze pole powierzchni zastawki aorty (AVA), płeć męska, obecność objawów oraz podwyższony poziom peptydu natriuretycznego typu B (BNP), który dodatkowo koreluje z potrzebą reoperacji. Zaawansowane modele predykcyjne oparte na uczeniu maszynowym, takie jak Random Survival Forest (AUC 0,83) oraz kliniczne narzędzia jak ASteRisk score, umożliwiają precyzyjną ocenę ryzyka zgonu lub konieczności wymiany zastawki w perspektywie 1-5 lat, także u pacjentów z niskim gradientem stenozowym (LGAS).

Choroba zastawki aorty – Rokowanie (przewidywanie wyników)

Choroba zastawki aorty, szczególnie zwężenie zastawki aorty (stenoza aortalna), wiąże się z niekorzystnym rokowaniem dla pacjentów niezależnie od stopnia nasilenia choroby. Zwężenie zastawki aorty staje się coraz bardziej powszechne wraz z wiekiem, dotykając głównie osób powyżej 65. roku życia.1 Kiedy u pacjentów z chorobą zastawki aorty pojawiają się objawy, takie jak duszność czy ból w klatce piersiowej, średnia długość życia wynosi zaledwie 1-2 lata bez leczenia, co daje gorsze rokowanie niż w przypadku większości nowotworów.2

Czynniki prognostyczne w chorobie zastawki aorty

Badania wykazały, że stopień zwężenia zastawki aorty ma znaczący wpływ na rokowanie. Umiarkowane zwężenie zastawki aorty wiąże się ze współczynnikiem ryzyka 1,57 (95% CI: 1,38-1,52; P 0,001), podczas gdy ciężkie zwężenie zastawki aorty zwiększa ryzyko niekorzystnych wyników ponad dwukrotnie (współczynnik ryzyka: 2,50; 95% CI: 2,32-2,70; P 0,001).3 Należy podkreślić, że ciężka objawowa stenoza aortalna jest stanem zagrażającym życiu.4

Wspólny model analizy z punktem końcowym w postaci śmierci wykazał, że mniejsze pole powierzchni zastawki aorty (AVA – Aortic Valve Area) na początku badania, płeć męska, występowanie objawów na początku badania oraz wyższy poziom peptydu natriuretycznego typu B (BNP) w określonym punkcie czasowym mają tendencję do związku ze zwiększoną śmiertelnością.5 Poziomy BNP zostały zidentyfikowane jako predyktory potrzeby reoperacji, co czyni je wiarygodnym wskaźnikiem śmiertelności i mogą być bardzo pomocne w planowaniu interwencji zapobiegających śmiertelności spowodowanej postępem choroby zastawki aorty.6

Modele predykcyjne w chorobie zastawki aorty

W ostatnich latach opracowano zaawansowane modele predykcyjne wykorzystujące techniki uczenia maszynowego (ML – Machine Learning) do przewidywania wyników u pacjentów z chorobą zastawki aorty. Model Random Survival Forest (RSF) wykazał obszar pod krzywą (AUC – Area Under the Curve) wynoszący 0,83 (95% CI: 0,80-0,86) i 0,83 (95% CI: 0,81-0,84) do przewidywania złożonego punktu końcowego (wymiana zastawki aorty lub śmiertelność) odpowiednio po 1 i 5 latach.7 Opracowany algorytm wykazał dobrą dokładność diagnostyczną, która utrzymywała się nawet podczas testowania na zewnętrznych kohortach, choć była nieco niższa w porównaniu z pierwotną kohortą.8

Jednym z takich modeli jest Aortic Stenosis Risk (ASteRisk) score, który wykorzystuje cechy echokardiograficzne i kliniczne do opracowania wyjaśnialnego klinicznego modelu przewidywania ryzyka u pacjentów ze stenozą aortalną, w tym u pacjentów z stenozą aortalną z niskim gradientem (LGAS – Low-Gradient Aortic Stenosis). Model ten przewiduje wyniki na okres do 5 lat obserwacji i jest dostępny online do użytku publicznego.9

Predykcja wyników po przezcewnikowej implantacji zastawki aortalnej (TAVI)

Przezcewnikowa implantacja zastawki aortalnej (TAVR/TAVI) jest szeroko stosowaną interwencją u pacjentów z ciężką stenozą aortalną. Identyfikacja pacjentów wysokiego ryzyka jest kluczowa ze względu na potencjalne powikłania po zabiegu.10 Opracowano model, który wykazuje AUROC (obszar pod krzywą charakterystyki operacyjnej odbiornika) wynoszący 0,725 dla przewidywania śmiertelności z wszystkich przyczyn w okresie obserwacji po zabiegu w kohorcie 1449 pacjentów poddanych TAVR.11

Model ten dostarcza przewidywania w ciągu 5-20 sekund na standardowym procesorze, w zależności od liczby brakujących zmiennych, co pozwala na ocenę pacjenta przy minimalnym nakładzie pracy manualnej.12 Co ważne, automatyczne wyodrębnianie cech może zastąpić ręcznie wyodrębniane pomiary obrazowe bez utraty dokładności predykcji, co jest istotnym i zaskakującym punktem.13 Ręczne wyodrębnianie takich cech dla każdego pacjenta może tworzyć wąskie gardło podczas przedoperacyjnej oceny pacjenta, ponieważ ręczne wydobycie pomiarów z pojedynczego obrazu zajmuje ekspertowi radiologowi od 10 do 15 minut, w zależności od nasilenia zwapnienia.14

Skala RELiEF TAVI dla pacjentów z LFLG AS

Dla pacjentów z stenozą aortalną z niskim przepływem i niskim gradientem (LFLG AS) oraz zmniejszoną frakcją wyrzutową lewej komory (LVEF), którzy są znani z niekorzystnego rokowania po TAVI, opracowano specjalny model predykcyjny.15 Skala RELiEF TAVI opiera się na prostych parametrach klinicznych, echokardiograficznych i tomografii komputerowej i może służyć jako pomocne narzędzie do przewidywania ryzyka u pacjentów z LFLG AS i zmniejszoną LVEF zakwalifikowanych do TAVI.16

Pacjenci z wysokim wynikiem RELiEF TAVI mieli ponad dwukrotny wzrost śmiertelności z wszystkich przyczyn lub hospitalizacji z powodu niewydolności serca, ponad 2,5-krotny wzrost śmiertelności z wszystkich przyczyn i czterokrotny wzrost śmiertelności z przyczyn sercowo-naczyniowych w ciągu 1 roku po TAVI w porównaniu z pacjentami z niskim wynikiem RELiEF TAVI.17 Skala RELiEF TAVI była lepsza od ustalonej skali EuroSCORE II w zakresie przewidywania ryzyka śmiertelności z wszystkich przyczyn i ponownych przyjęć z powodu niewydolności serca oraz zapewniała rozsądną wydajność dyskryminacyjną z jedynie niewielkimi rozbieżnościami między przewidywanymi przez skalę a obserwowanymi wskaźnikami śmiertelności.18 U pacjentów z wynikiem RELiEF TAVI 7 lub więcej, wskaźnik śmiertelności 1 rok po TAVI przekraczał 90%.19

Dynamiczne modele predykcyjne w chorobie zastawki aorty

Kardiolodzy wykorzystują różne rodzaje informacji do przewidywania rokowania pacjenta. Na przykład, w przypadku nowego pacjenta cierpiącego na ciężką stenozę aortalną, kardiolog bierze pod uwagę nie tylko stopień zwężenia zastawki aorty, ale także cechy pacjenta, historię medyczną i markery takie jak BNP.20 Małe pole powierzchni zastawki aorty i wysoki poziom BNP są związane z cięższym przebiegiem choroby i gorszym wynikiem.21

W oparciu o pojawiające się dowody dotyczące determinantów wyników w stenozie aortalnej oraz przy pomocy nowatorskich podejść statystycznych do modelowania wyników, możliwe jest teraz konstruowanie dynamicznych modeli predykcyjnych dla wyników pacjentów, wykorzystujących wielokrotnie zbierane (podłużne) dane, takie jak BNP, naśladujących dynamiczne dostosowywanie prognozy stosowane intuicyjnie przez kardiologów podczas każdej wizyty w przychodni.22

Wspólny model danych podłużnych i przeżycia stanowi potężne narzędzie statystyczne zdolne do uchwycenia związku między danymi podłużnymi a przeżyciem.23 Czasowe dostosowanie modeli predykcji ryzyka dla pacjentów z ciężką stenozą aortalną, w miarę jak więcej pomiarów BNP staje się dostępnych w czasie, zapewnia lekarzowi opartą na dowodach naukowych wiedzę na temat prognostycznych implikacji zmian stanu choroby pacjenta.24

Znaczenie wymiany zastawki aortalnej dla rokowania

Wymiana zastawki aortalnej jest jedynym skutecznym leczeniem dla stenozy aortalnej, jednak niestety co najmniej 1/3 pacjentów z stenozą zastawki aorty nie otrzymuje obecnie takiego leczenia.25 W badaniach z długim okresem obserwacji (mediana 48 miesięcy) 1116 pacjentów przeszło wymianę zastawki aortalnej (AVR), a 5069 pacjentów zmarło.26

Dzięki przezcewnikowej implantacji zastawki aortalnej (TAVR/TAVI), lekarze mają obecnie możliwość wykonania wymiany zastawki aortalnej za pomocą minimalnie inwazyjnych podejść, w tym zabiegów przezskórnych (interwencja bez nacięcia), które zapewniają wyniki równie dobre lub czasami lepsze niż chirurgiczna wymiana zastawki.27 To istotnie poprawiło rokowanie u pacjentów z chorobą zastawki aorty, szczególnie u osób starszych i z wysokim ryzykiem operacyjnym.

Podsumowanie rokowania w chorobie zastawki aorty

Choroba zastawki aorty, zwłaszcza stenoza aortalna, wiąże się z istotnym ryzykiem śmiertelności, szczególnie po wystąpieniu objawów. Zaawansowane modele predykcyjne oparte na uczeniu maszynowym umożliwiają obecnie dokładniejsze przewidywanie rokowania u pacjentów z chorobą zastawki aorty. Modele te wykorzystują dane kliniczne, echokardiograficzne, markery biochemiczne (jak BNP) oraz obrazowanie w celu stratyfikacji ryzyka i podejmowania decyzji terapeutycznych.2829

Algorytmy takie jak ASteRisk i RELiEF TAVI okazały się cennymi narzędziami w ocenie ryzyka, wspierając kardiologów w podejmowaniu decyzji o czasie i rodzaju interwencji. Odpowiednio wczesna wymiana zastawki aortalnej, szczególnie poprzez mniej inwazyjne techniki TAVI u pacjentów wysokiego ryzyka, znacząco poprawia rokowanie.3031

Dynamiczne modele predykcyjne, które uwzględniają zmiany w parametrach klinicznych i biochemicznych w czasie, odzwierciedlają rzeczywiste podejście do monitorowania pacjentów i mogą zapewnić bardziej spersonalizowaną ocenę ryzyka.3233 Zastosowanie tych zaawansowanych narzędzi prognostycznych oraz odpowiednie i terminowe interwencje mogą istotnie poprawić przeżywalność i jakość życia pacjentów z chorobą zastawki aorty.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Aortic Valve Disease | UNC Heart Valve Clinic
    https://www.med.unc.edu/medicine/cardiology/uncheartvalve/diseases-and-treatments/aortic-valve-disease/
    Aortic stenosis becomes increasingly common with age, predominantly affecting those over the age of 65. […] When symptoms, such as shortness of breath or chest pain, develop from aortic stenosis, the average life expectancy is only 1-2 years, with a prognosis that is worse than most cancers, if left untreated. […] Unfortunately, at least 1/3 of patients with aortic valve stenosis today are not receiving valve replacement, which is the only treatment that is effective for this condition. […] Severe symptomatic aortic stenosis is a life threatening condition. […] With TAVR, physicians now have the ability to provide aortic valve replacement via minimally-invasive approaches, including percutaneous procedures (intervention without an incision), which provide outcomes that are as good, or sometimes better than, surgical valve replacement.
  • #2 Aortic Valve Disease | UNC Heart Valve Clinic
    https://www.med.unc.edu/medicine/cardiology/uncheartvalve/diseases-and-treatments/aortic-valve-disease/
    Aortic stenosis becomes increasingly common with age, predominantly affecting those over the age of 65. […] When symptoms, such as shortness of breath or chest pain, develop from aortic stenosis, the average life expectancy is only 1-2 years, with a prognosis that is worse than most cancers, if left untreated. […] Unfortunately, at least 1/3 of patients with aortic valve stenosis today are not receiving valve replacement, which is the only treatment that is effective for this condition. […] Severe symptomatic aortic stenosis is a life threatening condition. […] With TAVR, physicians now have the ability to provide aortic valve replacement via minimally-invasive approaches, including percutaneous procedures (intervention without an incision), which provide outcomes that are as good, or sometimes better than, surgical valve replacement.
  • #3 Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11450950/
    Aortic valve stenosis of any degree is associated with poor outcomes. […] The authors aimed to develop a risk prediction model for aortic stenosis (AS) prognosis using machine learning techniques. […] The composite outcome included aortic valve replacement or mortality. […] In patients with AS, a machine learning algorithm predicts outcomes with good accuracy, and prognostic characteristics were identified. […] The model can potentially guide risk factor modification and clinical decisions to improve patient prognosis. […] The median follow-up of the primary cohort was 48 (21-87) months. During this period, 1,116 patients underwent AVR, and 5,069 patients died. […] Among others, moderate (hazard ratio: 1.57; 95% CI: 1.38-1.52; P 0.001) and severe (hazard ratio: 2.50; 95% CI: 2.32-2.70; P 0.001) AS were 2 of the most relevant predictors of outcome.
  • #4 Aortic Valve Disease | UNC Heart Valve Clinic
    https://www.med.unc.edu/medicine/cardiology/uncheartvalve/diseases-and-treatments/aortic-valve-disease/
    Aortic stenosis becomes increasingly common with age, predominantly affecting those over the age of 65. […] When symptoms, such as shortness of breath or chest pain, develop from aortic stenosis, the average life expectancy is only 1-2 years, with a prognosis that is worse than most cancers, if left untreated. […] Unfortunately, at least 1/3 of patients with aortic valve stenosis today are not receiving valve replacement, which is the only treatment that is effective for this condition. […] Severe symptomatic aortic stenosis is a life threatening condition. […] With TAVR, physicians now have the ability to provide aortic valve replacement via minimally-invasive approaches, including percutaneous procedures (intervention without an incision), which provide outcomes that are as good, or sometimes better than, surgical valve replacement.
  • #5 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    The joint model with the death as outcome shows that smaller AVA at baseline, male patient, symptoms at baseline and higher BNP at a specific time point tend to be associated with death. […] This approach provides the cardiologist with a useful evidence-based tool to assess the impact of BNP on patient prognosis. […] The joint model of longitudinal and survival data represents a powerful statistical tool capable of capturing the association between longitudinal and survival data. […] From the analysis we obtained a non-significant association between aortic valve intervention and the evolution of BNP. […] However, BNP levels have been previously found to be predictors of reoperation. Therefore, although BNP profile is not a good predictor of intervention in our case, it is reliable in predicting mortality and thus can be very helpful in planning an intervention to prevent mortality due to AS disease progression.
  • #6 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    The joint model with the death as outcome shows that smaller AVA at baseline, male patient, symptoms at baseline and higher BNP at a specific time point tend to be associated with death. […] This approach provides the cardiologist with a useful evidence-based tool to assess the impact of BNP on patient prognosis. […] The joint model of longitudinal and survival data represents a powerful statistical tool capable of capturing the association between longitudinal and survival data. […] From the analysis we obtained a non-significant association between aortic valve intervention and the evolution of BNP. […] However, BNP levels have been previously found to be predictors of reoperation. Therefore, although BNP profile is not a good predictor of intervention in our case, it is reliable in predicting mortality and thus can be very helpful in planning an intervention to prevent mortality due to AS disease progression.
  • #7 Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11450950/
    The RSF model showed an area under the curve (AUC) of 0.83 (95% CI: 0.80-0.86) and 0.83 (95% CI: 0.81-0.84) to predict the composite outcome at 1 and 5 years, respectively. […] The developed algorithm exhibited good diagnostic accuracy. When tested on external cohorts, the diagnostic accuracy remained good, albeit slightly lower compared to the primary cohort. […] Using advanced ML methods, we have developed an algorithm that accurately predicts patient outcomes across all grades of AS while identifying crucial prognosis-related variables.
  • #8 Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11450950/
    The RSF model showed an area under the curve (AUC) of 0.83 (95% CI: 0.80-0.86) and 0.83 (95% CI: 0.81-0.84) to predict the composite outcome at 1 and 5 years, respectively. […] The developed algorithm exhibited good diagnostic accuracy. When tested on external cohorts, the diagnostic accuracy remained good, albeit slightly lower compared to the primary cohort. […] Using advanced ML methods, we have developed an algorithm that accurately predicts patient outcomes across all grades of AS while identifying crucial prognosis-related variables.
  • #9 Predicting outcomes in patients with aortic stenosis using machine learning: the Aortic Stenosis Risk (ASteRisk) score – PubMed
    https://pubmed.ncbi.nlm.nih.gov/35641101/
    Objective: To use echocardiographic and clinical features to develop an explainable clinical risk prediction model in patients with aortic stenosis (AS), including those with low-gradient AS (LGAS), using machine learning (ML). […] Conclusion: In two separate longitudinal databases, ML identified prognostic features and produced an algorithm that predicts outcome for up to 5 years of follow-up in patients with AS, including patients with LGAS. Our algorithm, the Aortic Stenosis Risk (ASteRisk) score, is available online for public use.
  • #10 Predicting mortality after transcatheter aortic valve replacement using preprocedural CT | Scientific Reports
    https://www.nature.com/articles/s41598-024-63022-x
    Transcatheter aortic valve replacement (TAVR) is a widely used intervention for patients with severe aortic stenosis. Identifying high-risk patients is crucial due to potential postprocedural complications. […] Our model demonstrates an AUROC of 0.725 for predicting all-cause mortality during postprocedure follow-up on a cohort of 1449 TAVR patients. […] Thus, these findings underscore the potential of the proposed model in automatically analyzing CT volumes and integrating them with patient characteristics for predicting mortality after TAVR. […] In this study, we define the outcome as all-cause mortality during the postprocedural follow-up period. […] Among survivors, the median follow-up duration is 1093 days, with the 5th and 95th percentiles at 366 days and 2683 days, respectively. Across all patients, the two output classes are fairly balanced: 44% of patients passed away during follow-up (class 1) and 56% survived (class 0).
  • #11 Predicting mortality after transcatheter aortic valve replacement using preprocedural CT | Scientific Reports
    https://www.nature.com/articles/s41598-024-63022-x
    Transcatheter aortic valve replacement (TAVR) is a widely used intervention for patients with severe aortic stenosis. Identifying high-risk patients is crucial due to potential postprocedural complications. […] Our model demonstrates an AUROC of 0.725 for predicting all-cause mortality during postprocedure follow-up on a cohort of 1449 TAVR patients. […] Thus, these findings underscore the potential of the proposed model in automatically analyzing CT volumes and integrating them with patient characteristics for predicting mortality after TAVR. […] In this study, we define the outcome as all-cause mortality during the postprocedural follow-up period. […] Among survivors, the median follow-up duration is 1093 days, with the 5th and 95th percentiles at 366 days and 2683 days, respectively. Across all patients, the two output classes are fairly balanced: 44% of patients passed away during follow-up (class 1) and 56% survived (class 0).
  • #12 Predicting mortality after transcatheter aortic valve replacement using preprocedural CT | Scientific Reports
    https://www.nature.com/articles/s41598-024-63022-x
    Our model delivers a prediction within 5 to 20 seconds on a consumer CPU depending on the number of missing variables allowing patient assessment with minimal manual labor. […] The results in Table 2 confirm that our automatic feature extraction can replace manually extracted image measurements without forfeiting prediction accuracy, which is an important and surprising point. […] However, extracting such features for every patient can create a bottleneck during preprocedural patient assessment: Extracting the measurements manually from a single image takes an expert radiologist between 10 and 15 minutes depending on calcification severity.
  • #13 Predicting mortality after transcatheter aortic valve replacement using preprocedural CT | Scientific Reports
    https://www.nature.com/articles/s41598-024-63022-x
    Our model delivers a prediction within 5 to 20 seconds on a consumer CPU depending on the number of missing variables allowing patient assessment with minimal manual labor. […] The results in Table 2 confirm that our automatic feature extraction can replace manually extracted image measurements without forfeiting prediction accuracy, which is an important and surprising point. […] However, extracting such features for every patient can create a bottleneck during preprocedural patient assessment: Extracting the measurements manually from a single image takes an expert radiologist between 10 and 15 minutes depending on calcification severity.
  • #14 Predicting mortality after transcatheter aortic valve replacement using preprocedural CT | Scientific Reports
    https://www.nature.com/articles/s41598-024-63022-x
    Our model delivers a prediction within 5 to 20 seconds on a consumer CPU depending on the number of missing variables allowing patient assessment with minimal manual labor. […] The results in Table 2 confirm that our automatic feature extraction can replace manually extracted image measurements without forfeiting prediction accuracy, which is an important and surprising point. […] However, extracting such features for every patient can create a bottleneck during preprocedural patient assessment: Extracting the measurements manually from a single image takes an expert radiologist between 10 and 15 minutes depending on calcification severity.
  • #15 Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI | Open Heart
    https://openheart.bmj.com/content/9/1/e001912
    Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). […] The RELiEF TAVI score is based on simple clinical, echocardiographic and CT parameters and might serve as a helpful tool for risk prediction in patients with LFLG AS and reduced LVEF scheduled for TAVI. […] Patients with high RELiEF TAVI score had a more than twofold increase in all-cause mortality or HF hospitalisations, a more than 2.5-fold increase in all-cause mortality alone and a fourfold increase in cardiovascular mortality at 1 year after TAVI compared with those with low RELiEF TAVI score. […] The RELiEF TAVI score was superior to the established EuroSCORE II regarding risk prediction of all-cause mortality and HF readmissions and provided a reasonable discriminative performance with only minor discrepancies between score-predicted and observed mortality rates. […] In patients with a RELiEF TAVI score 7 or more, the mortality rate 1 year after TAVI was in excess of 90%.
  • #16 Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI | Open Heart
    https://openheart.bmj.com/content/9/1/e001912
    Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). […] The RELiEF TAVI score is based on simple clinical, echocardiographic and CT parameters and might serve as a helpful tool for risk prediction in patients with LFLG AS and reduced LVEF scheduled for TAVI. […] Patients with high RELiEF TAVI score had a more than twofold increase in all-cause mortality or HF hospitalisations, a more than 2.5-fold increase in all-cause mortality alone and a fourfold increase in cardiovascular mortality at 1 year after TAVI compared with those with low RELiEF TAVI score. […] The RELiEF TAVI score was superior to the established EuroSCORE II regarding risk prediction of all-cause mortality and HF readmissions and provided a reasonable discriminative performance with only minor discrepancies between score-predicted and observed mortality rates. […] In patients with a RELiEF TAVI score 7 or more, the mortality rate 1 year after TAVI was in excess of 90%.
  • #17 Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI | Open Heart
    https://openheart.bmj.com/content/9/1/e001912
    Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). […] The RELiEF TAVI score is based on simple clinical, echocardiographic and CT parameters and might serve as a helpful tool for risk prediction in patients with LFLG AS and reduced LVEF scheduled for TAVI. […] Patients with high RELiEF TAVI score had a more than twofold increase in all-cause mortality or HF hospitalisations, a more than 2.5-fold increase in all-cause mortality alone and a fourfold increase in cardiovascular mortality at 1 year after TAVI compared with those with low RELiEF TAVI score. […] The RELiEF TAVI score was superior to the established EuroSCORE II regarding risk prediction of all-cause mortality and HF readmissions and provided a reasonable discriminative performance with only minor discrepancies between score-predicted and observed mortality rates. […] In patients with a RELiEF TAVI score 7 or more, the mortality rate 1 year after TAVI was in excess of 90%.
  • #18 Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI | Open Heart
    https://openheart.bmj.com/content/9/1/e001912
    Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). […] The RELiEF TAVI score is based on simple clinical, echocardiographic and CT parameters and might serve as a helpful tool for risk prediction in patients with LFLG AS and reduced LVEF scheduled for TAVI. […] Patients with high RELiEF TAVI score had a more than twofold increase in all-cause mortality or HF hospitalisations, a more than 2.5-fold increase in all-cause mortality alone and a fourfold increase in cardiovascular mortality at 1 year after TAVI compared with those with low RELiEF TAVI score. […] The RELiEF TAVI score was superior to the established EuroSCORE II regarding risk prediction of all-cause mortality and HF readmissions and provided a reasonable discriminative performance with only minor discrepancies between score-predicted and observed mortality rates. […] In patients with a RELiEF TAVI score 7 or more, the mortality rate 1 year after TAVI was in excess of 90%.
  • #19 Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI | Open Heart
    https://openheart.bmj.com/content/9/1/e001912
    Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). […] The RELiEF TAVI score is based on simple clinical, echocardiographic and CT parameters and might serve as a helpful tool for risk prediction in patients with LFLG AS and reduced LVEF scheduled for TAVI. […] Patients with high RELiEF TAVI score had a more than twofold increase in all-cause mortality or HF hospitalisations, a more than 2.5-fold increase in all-cause mortality alone and a fourfold increase in cardiovascular mortality at 1 year after TAVI compared with those with low RELiEF TAVI score. […] The RELiEF TAVI score was superior to the established EuroSCORE II regarding risk prediction of all-cause mortality and HF readmissions and provided a reasonable discriminative performance with only minor discrepancies between score-predicted and observed mortality rates. […] In patients with a RELiEF TAVI score 7 or more, the mortality rate 1 year after TAVI was in excess of 90%.
  • #20 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    Physicians utilize different types of information to predict patient prognosis. For example: confronted with a new patient suffering from severe aortic stenosis (AS), the cardiologist considers not only the severity of the AS but also patient characteristics, medical history, and markers such as BNP. […] A small AVA and a high BNP are both associated with a more severe disease and a worse outcome. […] Based on emerging evidence on determinants of the outcome in AS, and with the help of novel statistical approaches to model outcomes, it is now possible to construct dynamic prediction models for patient outcome, employing repeatedly collected (longitudinal) data such as BNP, mimicking the dynamic adjustment of prognosis as employed intuitively by cardiologists at each outpatient clinic visit.
  • #21 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    Physicians utilize different types of information to predict patient prognosis. For example: confronted with a new patient suffering from severe aortic stenosis (AS), the cardiologist considers not only the severity of the AS but also patient characteristics, medical history, and markers such as BNP. […] A small AVA and a high BNP are both associated with a more severe disease and a worse outcome. […] Based on emerging evidence on determinants of the outcome in AS, and with the help of novel statistical approaches to model outcomes, it is now possible to construct dynamic prediction models for patient outcome, employing repeatedly collected (longitudinal) data such as BNP, mimicking the dynamic adjustment of prognosis as employed intuitively by cardiologists at each outpatient clinic visit.
  • #22 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    Physicians utilize different types of information to predict patient prognosis. For example: confronted with a new patient suffering from severe aortic stenosis (AS), the cardiologist considers not only the severity of the AS but also patient characteristics, medical history, and markers such as BNP. […] A small AVA and a high BNP are both associated with a more severe disease and a worse outcome. […] Based on emerging evidence on determinants of the outcome in AS, and with the help of novel statistical approaches to model outcomes, it is now possible to construct dynamic prediction models for patient outcome, employing repeatedly collected (longitudinal) data such as BNP, mimicking the dynamic adjustment of prognosis as employed intuitively by cardiologists at each outpatient clinic visit.
  • #23 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    The joint model with the death as outcome shows that smaller AVA at baseline, male patient, symptoms at baseline and higher BNP at a specific time point tend to be associated with death. […] This approach provides the cardiologist with a useful evidence-based tool to assess the impact of BNP on patient prognosis. […] The joint model of longitudinal and survival data represents a powerful statistical tool capable of capturing the association between longitudinal and survival data. […] From the analysis we obtained a non-significant association between aortic valve intervention and the evolution of BNP. […] However, BNP levels have been previously found to be predictors of reoperation. Therefore, although BNP profile is not a good predictor of intervention in our case, it is reliable in predicting mortality and thus can be very helpful in planning an intervention to prevent mortality due to AS disease progression.
  • #24 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    In conclusion, this paper has shown that temporal adjustment of risk prediction models for patients with severe AS, as more measurements of BNP become available over time, provide the physician with an evidence based understanding of the prognostic implication of changes in the patients disease condition.
  • #25 Aortic Valve Disease | UNC Heart Valve Clinic
    https://www.med.unc.edu/medicine/cardiology/uncheartvalve/diseases-and-treatments/aortic-valve-disease/
    Aortic stenosis becomes increasingly common with age, predominantly affecting those over the age of 65. […] When symptoms, such as shortness of breath or chest pain, develop from aortic stenosis, the average life expectancy is only 1-2 years, with a prognosis that is worse than most cancers, if left untreated. […] Unfortunately, at least 1/3 of patients with aortic valve stenosis today are not receiving valve replacement, which is the only treatment that is effective for this condition. […] Severe symptomatic aortic stenosis is a life threatening condition. […] With TAVR, physicians now have the ability to provide aortic valve replacement via minimally-invasive approaches, including percutaneous procedures (intervention without an incision), which provide outcomes that are as good, or sometimes better than, surgical valve replacement.
  • #26 Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11450950/
    Aortic valve stenosis of any degree is associated with poor outcomes. […] The authors aimed to develop a risk prediction model for aortic stenosis (AS) prognosis using machine learning techniques. […] The composite outcome included aortic valve replacement or mortality. […] In patients with AS, a machine learning algorithm predicts outcomes with good accuracy, and prognostic characteristics were identified. […] The model can potentially guide risk factor modification and clinical decisions to improve patient prognosis. […] The median follow-up of the primary cohort was 48 (21-87) months. During this period, 1,116 patients underwent AVR, and 5,069 patients died. […] Among others, moderate (hazard ratio: 1.57; 95% CI: 1.38-1.52; P 0.001) and severe (hazard ratio: 2.50; 95% CI: 2.32-2.70; P 0.001) AS were 2 of the most relevant predictors of outcome.
  • #27 Aortic Valve Disease | UNC Heart Valve Clinic
    https://www.med.unc.edu/medicine/cardiology/uncheartvalve/diseases-and-treatments/aortic-valve-disease/
    Aortic stenosis becomes increasingly common with age, predominantly affecting those over the age of 65. […] When symptoms, such as shortness of breath or chest pain, develop from aortic stenosis, the average life expectancy is only 1-2 years, with a prognosis that is worse than most cancers, if left untreated. […] Unfortunately, at least 1/3 of patients with aortic valve stenosis today are not receiving valve replacement, which is the only treatment that is effective for this condition. […] Severe symptomatic aortic stenosis is a life threatening condition. […] With TAVR, physicians now have the ability to provide aortic valve replacement via minimally-invasive approaches, including percutaneous procedures (intervention without an incision), which provide outcomes that are as good, or sometimes better than, surgical valve replacement.
  • #28 Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11450950/
    Aortic valve stenosis of any degree is associated with poor outcomes. […] The authors aimed to develop a risk prediction model for aortic stenosis (AS) prognosis using machine learning techniques. […] The composite outcome included aortic valve replacement or mortality. […] In patients with AS, a machine learning algorithm predicts outcomes with good accuracy, and prognostic characteristics were identified. […] The model can potentially guide risk factor modification and clinical decisions to improve patient prognosis. […] The median follow-up of the primary cohort was 48 (21-87) months. During this period, 1,116 patients underwent AVR, and 5,069 patients died. […] Among others, moderate (hazard ratio: 1.57; 95% CI: 1.38-1.52; P 0.001) and severe (hazard ratio: 2.50; 95% CI: 2.32-2.70; P 0.001) AS were 2 of the most relevant predictors of outcome.
  • #29 Machine Learning Prediction for Prognosis of Patients With Aortic Stenosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11450950/
    The RSF model showed an area under the curve (AUC) of 0.83 (95% CI: 0.80-0.86) and 0.83 (95% CI: 0.81-0.84) to predict the composite outcome at 1 and 5 years, respectively. […] The developed algorithm exhibited good diagnostic accuracy. When tested on external cohorts, the diagnostic accuracy remained good, albeit slightly lower compared to the primary cohort. […] Using advanced ML methods, we have developed an algorithm that accurately predicts patient outcomes across all grades of AS while identifying crucial prognosis-related variables.
  • #30 Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI | Open Heart
    https://openheart.bmj.com/content/9/1/e001912
    Patients with low-flow, low-gradient aortic stenosis (LFLG AS) and reduced left ventricular ejection fraction (LVEF) are known to suffer from poor prognosis after transcatheter aortic valve implantation (TAVI). […] The RELiEF TAVI score is based on simple clinical, echocardiographic and CT parameters and might serve as a helpful tool for risk prediction in patients with LFLG AS and reduced LVEF scheduled for TAVI. […] Patients with high RELiEF TAVI score had a more than twofold increase in all-cause mortality or HF hospitalisations, a more than 2.5-fold increase in all-cause mortality alone and a fourfold increase in cardiovascular mortality at 1 year after TAVI compared with those with low RELiEF TAVI score. […] The RELiEF TAVI score was superior to the established EuroSCORE II regarding risk prediction of all-cause mortality and HF readmissions and provided a reasonable discriminative performance with only minor discrepancies between score-predicted and observed mortality rates. […] In patients with a RELiEF TAVI score 7 or more, the mortality rate 1 year after TAVI was in excess of 90%.
  • #31 Predicting outcomes in patients with aortic stenosis using machine learning: the Aortic Stenosis Risk (ASteRisk) score – PubMed
    https://pubmed.ncbi.nlm.nih.gov/35641101/
    Objective: To use echocardiographic and clinical features to develop an explainable clinical risk prediction model in patients with aortic stenosis (AS), including those with low-gradient AS (LGAS), using machine learning (ML). […] Conclusion: In two separate longitudinal databases, ML identified prognostic features and produced an algorithm that predicts outcome for up to 5 years of follow-up in patients with AS, including patients with LGAS. Our algorithm, the Aortic Stenosis Risk (ASteRisk) score, is available online for public use.
  • #32 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    The joint model with the death as outcome shows that smaller AVA at baseline, male patient, symptoms at baseline and higher BNP at a specific time point tend to be associated with death. […] This approach provides the cardiologist with a useful evidence-based tool to assess the impact of BNP on patient prognosis. […] The joint model of longitudinal and survival data represents a powerful statistical tool capable of capturing the association between longitudinal and survival data. […] From the analysis we obtained a non-significant association between aortic valve intervention and the evolution of BNP. […] However, BNP levels have been previously found to be predictors of reoperation. Therefore, although BNP profile is not a good predictor of intervention in our case, it is reliable in predicting mortality and thus can be very helpful in planning an intervention to prevent mortality due to AS disease progression.
  • #33 Dynamic prediction of outcome for patients with severe aortic stenosis: application of joint models for longitudinal and time-to-event data | BMC Cardiovascular Disorders | Full Text
    https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-015-0035-z
    In conclusion, this paper has shown that temporal adjustment of risk prediction models for patients with severe AS, as more measurements of BNP become available over time, provide the physician with an evidence based understanding of the prognostic implication of changes in the patients disease condition.